The receptor for interleukin-17E is induced by Th2 cytokines in antigen-presenting cells

Scandinavian Journal of Immunology

Volumn 60, Issue 3, 2004, Pages 233-237

  Gratchev, A ^a,b   Kzhyshkowska, J ^a   Duperrier, K ^a   Utikal, J ^a   Velten, F W ^a   Goerdt, S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN RECEPTOR; MESSENGER RNA; MONOKINE; TRANSFORMING GROWTH FACTOR BETA;

ACCESSORY CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL MEMBRANE; CELL POPULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; SPLEEN CELL; TH2 CELL;

ALTERNATIVE SPLICING; ANTIGEN-PRESENTING CELLS; CYTOKINES; HUMANS; INTERLEUKIN-17; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-17; RECOMBINANT PROTEINS; RNA, MESSENGER; TH2 CELLS;

EID: 4344586523     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01443.x     Document Type: Article

References (23)

1. Fort MM, Cheung J, Yen D et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001;15: 985-95.
2. Ikeda K, Nakajima H, Suzuki K et al. Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation. Blood 2003;101: 3594-6.
3. Hurst SD, Muchamuel T, Gorman DM et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 2002;169: 443-53.
4. Pan G, French D, Mao W et al. Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice. J Immunol 2001;167: 6559-67.
5. Shi Y, Ullrich SJ, Zhang J et al. A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem 2000;275: 19167-76.
6. Lee J, Ho WH, Maruoka M et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 2001; 276: 1660-4.
7. Tian E, Sawyer JR, Largaespada DA, Jenkins NA, Copeland NG, Shaughnessy Jr JD. Evi27 encodes a novel membrane protein with homology to the IL17 receptor. Oncogene 2000;19: 2098-109.
8. Kodelja V, Muller C, Politz O, Hakij N, Orfanos CE, Goerdt S. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J Immunol 1998;160: 1411-8.
9. Goerdt S, Orfanos CE. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999;10: 137-42.
10. Gratchev A, Schledzewski K, Guillot P, Goerdt S. Alternatively activated antigen-presenting cells: molecular repertoire, immune regulation, and healing. Skin Pharmacol Appl Skin Physiol 2001;14: 272-9.
11. Politz O, Gratchev A, McCourt PA et al. Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J 2002; 362: 155-64.
12. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35.
13. Falcone FH, Loke P, Zang X, MacDonald AS, Maizels RM, Allen JE. A Brugia malayi homolog of macrophage migration inhibitory factor reveals an important link between macrophages and eosinophil recruitment during nematode infection. J Immunol 2001;167: 5348-54.
14. Gratchev A, Guillot P, Haldy N et al. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol 2001;53: 386-92.
15. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000;192: 1213-22.
16. Woltman AM, de Fijter JW, Kamerling SW, Paul LC, Daha MR, van Kooten C. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol 2000;30: 1807-12.
17. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997;159: 4772-80.
18. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003;14: 155-74.
19. Kim MR, Manoukian R, Yeh R et al. Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production. Blood 2002; 100: 2330-40.
20. Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 2001;15: 43-58.
21. Kruse S, Forster J, Kuehr J, Deichmann KA. Characterization of the membrane-bound and a soluble form of human IL-4 receptor alpha produced by alternative splicing. Int Immunol 1999;11: 1965-70.
22. Haudenschild D, Moseley T, Rose L, Reddi AH. Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer. J Biol Chem 2002;277: 4309-16.
23. Jung T, Wagner K, Neumann C, Heusser CH. Enhancement of human IL-4 activity by soluble IL-4 receptors in vitro. Eur J Immunol 1999;29: 864-71.